Reneuron en es it fr

Reneuron Brand names, Reneuron Analogs

Reneuron Brand Names Mixture

  • No information avaliable

Reneuron Chemical_Formula


Reneuron RX_link

Reneuron fda sheet

Reneuron FDA

Reneuron msds (material safety sheet)

Reneuron MSDS

Reneuron Synthesis Reference

B. B. Mally; K. K. Schmiegel; U.S. Pat. 4,314,081 (1982)

Reneuron Molecular Weight

309.326 g/mol

Reneuron Melting Point


Reneuron H2O Solubility

50 mg/mL at 25°C

Reneuron State


Reneuron LogP


Reneuron Dosage Forms

Capsule; Liquid; Solution

Reneuron Indication

For the treatment of depression, obsessive compulsive disorder, and bulimia nervosa.

Reneuron Pharmacology

Fluoxetine, an antidepressant agent belonging to the selective serotonin reuptake inhibitors (SSRIs), is used to treat depression, bulimia nervosa, premenstrual dysphoric disorder, panic disorder and post-traumatic stress. According to the amines hypothesis, a functional decrease in the activity of amines, such as serotonin and norepinephrine, would result in depression; a functional increase of the activity of these amines would result in mood elevation. Fluoxetine's effects are thought to be associated with the inhibition of 5HT receptor, which leads to an increase of serotonin level.

Reneuron Absorption


Reneuron side effects and Toxicity

Symptoms of overdose include agitation, restlessness, hypomania, and other signs of CNS excitation. LD50=284mg/kg (orally in mice).

Reneuron Patient Information

Reneuron Organisms Affected

Humans and other mammals